EGF receptor-targeting cancer therapy using CD47 : vimarsana

Evaluating the nanoparticles expressing CD47 proteins inhibiting the phagocytic attack of immune cells and as an anti-cancer drug delivery vehicle

Related Keywords

Germany , New York , United States , Hopkinton , Seoul , Soult Ukpyolsi , South Korea , Japan , Tokyo , Seongnam , Kyonggi Do , United Kingdom , Malvern , Worcestershire , China , Beijing , Heidenheim , Baden Wüberg , Chicago , Illinois , Chemidoc Vilber Lourmat , Unreacted Traut , Merck Kgaa Darmstadt , Malvern Instruments Ltd , Vector Lab , Graphpad Software Inc , Becton Dickinson , Sonics Materials Inc , Avanti Polar Lipid Inc , Sino Biological Inc , Cell Signaling Technology , Caliper Life Sciences , Yonsei University At Wonju , Ge Healthcare , Physicochemical Characterization , Macrophage Uptake , Tumor Growth Inhibition , Avanti Polar Lipid , Sino Biological , Merck Kgaa , American Type Culture Collection , Institutional Animal Care , Use Committee , Yonsei University , Materials Inc , Thermo Scientific , Malvern Instruments , Bethyl Laboratories , West Pico , Fusion Solo Chemidoc , Vilber Lourmat , Cell Counting , Dojindo Laboratories , Graphpad Prism , Graphpad Software , San Jose , Molecular Probes , Dependent Cell Binding , Alexa Fluor , Orient Bio ,